Get the Stockscreener App
10.80
2.81%
0.295
After Hours:
10.98
0.18
+1.67%
Rallybio Corp Stock (RLYB) Forecast
The Rallybio Corp (RLYB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5461, representing a -94.94% decrease from the current price of $10.80. The highest analyst price target is $1.0674, and the lowest is $0.0248.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RLYB Price Target
Average 2.2268
(-79.38% Downside)
Is Rallybio Corp (RLYB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 83.81 | Sell |
| STOCH(9,6) | 92.34 | Sell |
| STOCHRSI(14) | 90.63 | Sell |
| MACD(12,26) | 1.3434 | Buy |
| ADX(14) | 34.48 | Buy |
| William %R | -8.8236 | Sell |
| CCI(14) | 139.70 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.953
Buy
|
8.5521
Buy
|
| MA20 |
6.3156
Buy
|
7.2222
Buy
|
| MA50 |
5.7996
Buy
|
6.1378
Buy
|
| MA100 |
5.4836
Buy
|
5.6042
Buy
|
| MA200 |
4.6337
Buy
|
5.4204
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, RLYB could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on RLYB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 83.81 indicates that RLYB is overbought. This suggests that RLYB price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 92.34 indicates that RLYB is oversold. This means that RLYB price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 90.63 indicates that RLYB is oversold. This suggests that RLYB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.48 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 139.7 indicates that RLYB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RLYB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rallybio Corp financial reports and earnings history, Rallybio Corp (RLYB) stock could reach $3.7904 by 2030, $50.66 by 2040 and $71.03 by 2050. See the projected annual prices until 2050 of the Rallybio Corp stock below:
- Rallybio Corp (RLYB) is expected to reach an average price of $17.54 in 2035, with a high prediction of $18.03 and a low estimate of $15.30. This indicates an $62.36% rise from the last recorded price of $10.80.
- Rallybio Corp (RLYB) stock is projected to chart a bullish course in 2040, with an average price target of $50.26, representing an $365.38% surge from its current level. The forecast ranges from a conservative $50.95 to a sky-high $50.66.
- Our analysts predict Rallybio Corp (RLYB) to jump 175.36% by 2045, soaring from $29.93 to an average price of $29.74, potentially reaching $31.35. While $29.93 is the low estimate, the potential upside is significant.
- Rallybio Corp (RLYB) stock is expected to climb by 2050, reaching an average of $70.18, a $549.82% jump from its current level. However, a wide range of estimates exists, with high and low targets of $71.03 and $70.96, respectively, highlighting the market's uncertainty.
Rallybio Corp Stock (RLYB) Year by Year Forecast
Rallybio Corp Stock (RLYB) Price Forecast for 2026
The predicted value for Rallybio Corp (RLYB) in 2026 is set at an average of $2.2268. Estimates vary from a peak of $4.4288 to a trough of $0.0248, indicating an -79.38% surge from the present price of $10.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $0.2174 | $0.0248 | $1.0674 | -97.99% |
| May, 2026 | $3.2325 | $0.2337 | $3.3425 | -70.07% |
| June, 2026 | $1.1176 | $0.9226 | $4.4288 | -89.65% |
| July, 2026 | $1.7191 | $0.5702 | $2.0065 | -84.08% |
| August, 2026 | $1.4342 | $0.8866 | $2.2379 | -86.72% |
| September, 2026 | $1.1056 | $0.8906 | $2.1494 | -89.76% |
| October, 2026 | $0.1492 | $0.1992 | $1.3019 | -98.62% |
| November, 2026 | $0.4341 | $0.1229 | $1.1834 | -95.98% |
| December, 2026 | $0.1327 | $1.0327 | $0.7889 | -98.77% |
Rallybio Corp Stock (RLYB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rallybio Corp (RLYB) is $4.3369, with a high forecast of $8.6257 and a low forecast of $0.0481. This indicates an -59.84% decrease from the last price of $10.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6775 | $0.3164 | $0.3736 | -93.73% |
| February, 2027 | $1.2224 | $0.8912 | $1.1356 | -88.68% |
| March, 2027 | $0.0341 | $0.5608 | $1.1161 | -99.68% |
| April, 2027 | $0.4658 | $0.0553 | $0.4016 | -95.69% |
| May, 2027 | $0.0807 | $0.1907 | $1.5631 | -99.25% |
| June, 2027 | $8.4674 | $0.0481 | $7.7574 | -21.60% |
| July, 2027 | $8.2271 | $8.467 | $7.9535 | -23.82% |
| August, 2027 | $2.9569 | $3.2769 | $6.6146 | -72.62% |
| September, 2027 | $5.004 | $2.9666 | $3.0617 | -53.67% |
| October, 2027 | $7.6737 | $7.0714 | $6.0163 | -28.95% |
| November, 2027 | $9.5635 | $8.7312 | $7.6635 | -11.45% |
| December, 2027 | $6.3806 | $6.5706 | $8.6257 | -40.92% |
Rallybio Corp Stock (RLYB) Price Forecast for 2028
In 2028, Rallybio Corp (RLYB) is projected to reach an average price of $5.6663, with a high projection of $10.07 and a low estimate of $1.2578. This indicates an -47.53% fall from the last price of $10.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.5103 | $5.2655 | $4.5903 | -39.72% |
| February, 2028 | $9.36 | $7.1678 | $7.3826 | -13.33% |
| March, 2028 | $8.0472 | $9.3172 | $10.07 | -25.49% |
| April, 2028 | $5.6569 | $7.3569 | $5.762 | -47.62% |
| May, 2028 | $8.9341 | $3.7342 | $6.7141 | -17.28% |
| June, 2028 | $8.0738 | $8.4038 | $8.5015 | -25.24% |
| July, 2028 | $5.8335 | $6.3035 | $6.4512 | -45.99% |
| August, 2028 | $3.5506 | $3.0658 | $3.6409 | -67.12% |
| September, 2028 | $0.5504 | $2.0804 | $2.8481 | -94.90% |
| October, 2028 | $5.8201 | $1.2578 | $4.3301 | -46.11% |
| November, 2028 | $7.5172 | $4.1949 | $6.886 | -30.40% |
| December, 2028 | $7.7569 | $7.3895 | $6.8969 | -28.18% |
Rallybio Corp Stock (RLYB) Price Forecast for 2029
The 2029 price forecast for Rallybio Corp Stock (RLYB) is $3.9696 on average, with a high prediction of $6.1768 and a low estimate of $1.7624. This represents an -63.24% decrease from the previous price of $10.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.9541 | $6.6741 | $6.1768 | -44.87% |
| February, 2029 | $5.2238 | $5.089 | $4.9515 | -51.63% |
| March, 2029 | $3.3535 | $3.6385 | $4.2638 | -68.95% |
| April, 2029 | $6.2233 | $3.521 | $5.6933 | -42.38% |
| May, 2029 | $4.8204 | $5.6704 | $5.543 | -55.37% |
| June, 2029 | $3.4101 | $3.8901 | $4.3078 | -68.42% |
| July, 2029 | $1.7498 | $1.7624 | $2.3358 | -83.80% |
| August, 2029 | $2.587 | $2.1473 | $2.9221 | -76.05% |
| September, 2029 | $2.4967 | $2.5819 | $2.4419 | -76.88% |
| October, 2029 | $2.4139 | $2.639 | $2.3116 | -77.65% |
| November, 2029 | $3.6836 | $2.8213 | $3.2436 | -65.89% |
| December, 2029 | $2.6333 | $3.1483 | $3.201 | -75.62% |
Rallybio Corp Stock (RLYB) Price Forecast for 2030
Rallybio Corp Stock (RLYB) is expected to reach an average price of $10.05 in 2030, with a high forecast of $18.63 and a low forecast of $1.4636. This signifies an -6.97% decrease from the last price of $10.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3604 | $2.9207 | $3.7904 | -59.63% |
| February, 2030 | $3.1802 | $3.2702 | $3.8679 | -70.55% |
| March, 2030 | $3.9299 | $3.3876 | $3.4499 | -63.61% |
| April, 2030 | $3.1496 | $3.6946 | $3.7079 | -70.84% |
| May, 2030 | $2.4868 | $2.1793 | $2.737 | -76.97% |
| June, 2030 | $2.2765 | $2.3465 | $2.4316 | -78.92% |
| July, 2030 | $1.5762 | $1.4636 | $1.6888 | -85.41% |
| August, 2030 | $17.76 | $19.09 | $18.63 | +64.48% |
| September, 2030 | $13.66 | $18.19 | $17.66 | +26.46% |
| October, 2030 | $12.57 | $13.56 | $13.23 | +16.42% |
| November, 2030 | $16.52 | $13.02 | $15.02 | +52.95% |
| December, 2030 | $18.70 | $17.45 | $17.14 | +73.17% |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):